- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 22, 2025 | 50.85M sh |
| Long Term Debt | Q1 2025 · Mar 29, 2025 | $2.1B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.09B |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $879M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $901M |
| Cash And Equivalents | Q1 2025 · Mar 30, 2024 | $127M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $1.58B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.7B |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $4.27B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.38B |
| Current Assets | Q1 2025 · Mar 29, 2025 | $2.29B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.44B |
| Total Assets | Q1 2025 · Mar 29, 2025 | $7.9B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.97B |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 51.79M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $0 |
| Capex | Q1 2025 · Mar 30, 2024 | $14M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | $125M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $3.17B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.04B |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $2.23 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $2.24 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $81M |
| Rd Expense | Q1 2025 · Mar 30, 2024 | $138M |
| Net Income | Q1 2025 · Mar 30, 2024 | $115M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $159M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $563M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $612M |
| Revenue | Q1 2025 · Mar 30, 2024 | $1.18B |